Radio-immunomics in hepatocellular carcinoma: Unraveling the tumor immune microenvironment

Qianyun Liu; Wenwei Zhu; Fulong Song; Tuo Lou; Lei He; Wenming Zhou; Zhichao Feng

Meta-Radiology (Sep 2024)

Radio-immunomics in hepatocellular carcinoma: Unraveling the tumor immune microenvironment

Qianyun Liu,
Wenwei Zhu,
Fulong Song,
Tuo Lou,
Lei He,
Wenming Zhou,
Zhichao Feng

Affiliations

Qianyun Liu: Department of Medical Imaging, Yueyang Central Hospital, Yueyang, Hunan, China; Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Wenwei Zhu: Department of Radiology, Loudi Central Hospital, Loudi, Hunan, China
Fulong Song: Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Tuo Lou: Department of Medical Imaging, Yueyang Central Hospital, Yueyang, Hunan, China
Lei He: Department of Medical Imaging, Yueyang Central Hospital, Yueyang, Hunan, China
Wenming Zhou: Department of Medical Imaging, Yueyang Central Hospital, Yueyang, Hunan, China; Corresponding authors.
Zhichao Feng: Department of Medical Imaging, Yueyang Central Hospital, Yueyang, Hunan, China; Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China; SJTU-Ruijin-UIH Institute for Medical Imaging Technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Corresponding authors.

Journal volume & issue: Vol. 2, no. 3
p. 100098

Abstract

Read online

Hepatocellular carcinoma (HCC) ranks as the sixth most prevalent and the fourth most lethal malignancy worldwide, frequently manifesting at advanced stages with limited therapeutic options. Despite notable therapeutic advancements, challenges persist in precisely identifying patients likely to respond to immune-checkpoint inhibitors (ICIs). The tumor immune microenvironment (TIME) plays a pivotal role in the biological behavior of HCC, necessitating non-invasive methods for a comprehensive assessment prior to treatment initiation. Spatiotemporal molecular medicine, particularly radio-immunomics, emerges as a promising approach through integrating multi-omics data to decode the TIME. This review delineates the intricate TIME characteristics of HCC, summarizes recent advancements in radiomics for immune profiling within the framework of spatiotemporal molecular medicine, and delves into challenges and future prospects of radio-immunomics, highlighting the dynamic interplay of radiomics, genomics, and immunobiology. The evolving field of radio-immunomics holds unparalleled potential for non-invasive, personalized characterization of TIME in HCC, providing avenues to inform tailored treatments and optimize patient outcomes.

Published in Meta-Radiology

ISSN: 2950-1628 (Online)
Publisher: KeAi Communications Co., Ltd.
Country of publisher: China
LCC subjects: Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
Website: https://www.keaipublishing.com/en/journals/meta-radiology/

About the journal

Abstract

Keywords